A Novel System for Estimating Residual Disease and Pathologic Response to Neoadjuvant Treatment of Prostate Cancer
Author:
Affiliation:
1. Department of Pathology; University of Washington; Seattle Washington
2. Fred Hutchinson Cancer Research Center; Seattle Washington
3. Department of Medical Oncology; University of Washington; Seattle Washington
Funder
Pacific Northwest Prostate Cancer SPORE
Publisher
Wiley
Subject
Urology,Oncology
Reference36 articles.
1. Effects of complete androgen blockade for 12 and 24 weeks on the pathological stage and resection margin status of prostate cancer;Selli;J Clin Pathol,2002
2. Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer. the lupron depot neoadjuvant prostate cancer study group;Soloway;J Urol,1995
3. Effects of long-term finasteride treatment on prostate cancer morphology and clinical outcome;Rubin;Urology,2005
4. Morphologic characterization of preoperatively treated prostate cancer: Toward a post-therapy histologic classification;Efstathiou;Eur Urol,2010
5. Implications of the international society of urological pathology modified gleason grading system;Egevad;Arch Pathol Lab Med,2012
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Predictive factors associated with differential pathologic response to neoadjuvant chemohormonal therapy in high-risk localized prostate cancer;Urologic Oncology: Seminars and Original Investigations;2023-08
2. Nomogram for predicting the biochemical recurrence of prostate cancer after neoadjuvant androgen deprivation therapy;International Urology and Nephrology;2023-06-12
3. Neoadjuvant Hormonal Therapy for Prostate Cancer: Morphologic Features and Predictive Parameters of Therapy Response;Advances in Anatomic Pathology;2022-04-13
4. Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer;Nature Reviews Urology;2021-09-15
5. Targeting backdoor androgen synthesis through AKR1C3 inhibition: A presurgical hormonal ablative neoadjuvant trial in high‐risk localized prostate cancer;The Prostate;2021-03-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3